We quantified the SSTR2 immunohistochemistry signal in 79 tissue sections from 53 ILD patients and 26 control patients, and correlated this signal with the severity of fibrotic remodeling using an Ashcroft scoring (Fig 7H). Here, SSTR2 is linked to interstitial lung disease.